The DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal study and offering flexible pathways which earlier would have taken months. It said applications from companies will be given “high priority” and that it will assist the companies in speeding up their research.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2wuB8uz
via IFTTT
Subscribe to:
Post Comments (Atom)
-
By Reuters via NYT World https://ift.tt/2vrReVu
-
The peril posed by the twin scourges of pestilence and material ruin brought on by the swift advance of the coronavirus deepened on Friday a...
-
By Christoph Koettl and Meg Felling via NYT World https://ift.tt/38m0Y0Q
No comments:
Post a Comment